Cargando…

Atrial fibrillation and heart failure: A contemporary review of current management approaches

Atrial fibrillation (AF) and heart failure (HF) frequently coexist and complicate the course of treatment of each other. AF with rapid ventricular conduction can lead to tachycardia-mediated cardiomyopathy, which is a reversible cause of cardiomyopathy. However, in most cases, AF is the manifestatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Justin Z., Cha, Yong-Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Atrial Fibrillation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710620/ https://www.ncbi.nlm.nih.gov/pubmed/34988528 http://dx.doi.org/10.1016/j.hroo.2021.11.006

Ejemplares similares

Genetic risk and atrial fibrillation in patients with heart failure
por: Kloosterman, Mariëlle, et al.
Publicado: (2020)

Atrial fibrillation in heart failure: Prime time for ablation!
por: Deisenhofer, Isabel
Publicado: (2021)

Atrial Fibrillation in Congenital Heart Disease
por: Martín de Miguel, Irene, et al.
Publicado: (2021)

Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation
por: Ariyaratnam, Jonathan P., et al.
Publicado: (2021)

Safety, Efficacy and Prognostic Benefit of Atrial Fibrillation Ablation in Heart Failure with Preserved Ejection Fraction
por: Johner, Nicolas, et al.
Publicado: (2022)

Neuromodulatory Approaches for Atrial Fibrillation Ablation
por: Rodríguez-Mañero, Moisés, et al.
Publicado: (2021)

Atrial fibrillation in cardiac resynchronization therapy
por: Elliott, Mark K., et al.
Publicado: (2021)

Future Directions for Mapping Atrial Fibrillation
por: Zaman, Junaid AB, et al.
Publicado: (2022)

Pulsed Field Ablation for Atrial Fibrillation
por: Schaack, David, et al.
Publicado: (2023)

Management of Atrial Fibrillation Using Immunoglobulin Free Light Chains, Novel Biomarkers of Inflammation
por: Matsumori, Akira
Publicado: (2022)

Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation
por: Harmon, David M, et al.
Publicado: (2023)

Ablation as First-line Therapy for Atrial Fibrillation
por: Andrade, Jason G
Publicado: (2023)

Ganglionic Plexus Ablation: A Step-by-step Guide for Electrophysiologists and Review of Modalities for Neuromodulation for the Management of Atrial Fibrillation
por: Aksu, Tolga, et al.
Publicado: (2023)

Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation
por: Andrade, Jason G, et al.
Publicado: (2022)

Gut Microbiota and Atrial Fibrillation: Pathogenesis, Mechanisms and Therapies
por: Al-Kaisey, Ahmed M, et al.
Publicado: (2023)

Atrial fibrillation and 24‐h ambulatory blood pressure pattern
por: Verberk, Willem J.
Publicado: (2022)

Association Between Left Atrial Appendage Morphology and Function and the Risk of Ischaemic Stroke in Patients with Atrial Fibrillation
por: Dudziñska-Szczerba, Katarzyna, et al.
Publicado: (2022)

Considerations for the Assessment of Substrates, Genetics and Risk Factors in Patients with Atrial Fibrillation
por: Linz, Dominik, et al.
Publicado: (2021)

Atrial fibrillation is associated with increased central blood pressure and arterial stiffness
por: Pauklin, Priit, et al.
Publicado: (2021)

Mapping Technologies for Catheter Ablation of Atrial Fibrillation Beyond Pulmonary Vein Isolation
por: Rosa, Giulio La, et al.
Publicado: (2021)

Clinical Relevance of Sinus Rhythm Mapping to Quantify Electropathology Related to Atrial Fibrillation
por: van Schie, Mathijs S, et al.
Publicado: (2022)

Ambulatory blood pressure and risk of new‐onset atrial fibrillation in treated hypertensive patients
por: Coccina, Francesca, et al.
Publicado: (2020)

A Chronicle of Hybrid Atrial Fibrillation Ablation Therapy: From Cox Maze to Convergent
por: Kaba, Riyaz A, et al.
Publicado: (2022)

Prevalence and prognosis of atrial fibrillation in a hypertensive population: A prospective cohort study
por: Wang, Chang, et al.
Publicado: (2023)

Prevalence of atrial fibrillation and the risk of cardiovascular mortality among hypertensive elderly population in northeast China
por: Xia, Zhenwei, et al.
Publicado: (2022)

Prediction of atrial fibrillation in patients with hypertension: A comprehensive comparison of office and ambulatory blood pressure measurements
por: Huang, Pin‐Hsiang, et al.
Publicado: (2022)

Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should Know
por: Merella, Pierluigi, et al.
Publicado: (2023)

‘Pill-in-the-pocket’ Oral Anticoagulation Guided by Daily Rhythm Monitoring for Stroke Prevention in Patients with AF: A Systematic Review and Meta-analysis
por: Briosa e Gala, Andre, et al.
Publicado: (2023)

PITX2‐dependent gene regulation in atrial fibrillation and rhythm control
por: Syeda, Fahima, et al.
Publicado: (2017)

Disagreement of ESC guidelines from 2016 and 2021 and HFA-PEFF and H2 FPEF scores in diagnosis of heart failure with preserved ejection fraction in atrial fibrillation patients
por: Gawalko, M, et al.
Publicado: (2023)

Systolic, diastolic blood pressure and pulse pressure and risk of stroke in young aged patients with atrial fibrillation
por: Lee, S R, et al.
Publicado: (2023)

Incidence of atrial fibrillation in patients with central retinal artery occlusion: A Systematic Review and Meta-Analysis
por: Nedios, S, et al.
Publicado: (2023)

Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Cancer
por: Shabtaie, Samuel A., et al.
Publicado: (2023)

Predictors of stroke or systemic embolism in patients with non-valvular atrial fibrillation with CHA2DS2-VASc score of 0
por: Park, Y, et al.
Publicado: (2023)

Atrial fibrillation and in-hospital mortality in Covid-19 patients
por: Kotadia, I, et al.
Publicado: (2023)

Lower dose direct oral anticoagulation or warfarin in atrial fibrillation. Which one is the best when time on therapeutic range information is available?
por: Luojus, A, et al.
Publicado: (2023)

How often atrial flutter and atrial fibrillation coexist? Results from a large nationwide ECG-based study
por: Aro, A, et al.
Publicado: (2023)

Heart rate fragmentation as a marker of altered activity of the autonomic nervous system activity : a novel predictor of atrial fibrillation occurrence in the general population
por: Guichard, J B, et al.
Publicado: (2023)

Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical Trials
por: Alexandre, Joachim, et al.
Publicado: (2023)

Clustering of cardiovascular and renal comorbidities and risk of incident atrial fibrillation in the community-based PREVEND cohort
por: Van Deutekom, C, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_60qehpk8mrdhv88c5dhlciq2gf